Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation
Yuan‐Hung Lo, Kevin S. Kolahi, Yuhong Du, et al.
Cancer Discovery (2021) Vol. 11, Iss. 6, pp. 1562-1581
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer
Vikrant Kumar, Kalpana Ramnarayanan, Raghav Sundar, et al.
Cancer Discovery (2021) Vol. 12, Iss. 3, pp. 670-691
Open Access | Times Cited: 324
Tumor organoids: applications in cancer modeling and potentials in precision medicine
Hanxiao Xu, Dechao Jiao, Aiguo Liu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 140
Promises and challenges of organoid-guided precision medicine
Shree Bose, Hans Clevers, Xiling Shen
Med (2021) Vol. 2, Iss. 9, pp. 1011-1026
Open Access | Times Cited: 116
Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
Zilong Zhou, Lele Cong, Xianling Cong
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 107
Organoids in gastrointestinal diseases: from experimental models to clinical translation
Claudia Günther, Beate Winner, Markus F. Neurath, et al.
Gut (2022) Vol. 71, Iss. 9, pp. 1892-1908
Open Access | Times Cited: 84
Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine
Sanae El Harane, Bochra Zidi, Nadia El Harane, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 1001-1001
Open Access | Times Cited: 66
CRISPR engineering in organoids for gene repair and disease modelling
Maarten H. Geurts, Hans Clevers
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 1, pp. 32-45
Open Access | Times Cited: 49
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
Roel Polak, Elisa Zhang, Calvin J. Kuo
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 523-539
Closed Access | Times Cited: 48
Deterministic evolution and stringent selection during preneoplasia
Kasper Karlsson, Moritz J. Przybilla, Eran Kotler, et al.
Nature (2023) Vol. 618, Iss. 7964, pp. 383-393
Open Access | Times Cited: 45
Organoid cultures for cancer modeling
Helen H.N. Yan, April Chan, Frank Pui-Ling Lai, et al.
Cell stem cell (2023) Vol. 30, Iss. 7, pp. 917-937
Open Access | Times Cited: 42
Construction of tumor organoids and their application to cancer research and therapy
Jiajing Lv, Xuan Du, Miaomiao Wang, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 1101-1125
Open Access | Times Cited: 21
Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression
Kie Kyon Huang, Haoran Ma, Roxanne Hui Heng Chong, et al.
Cancer Cell (2023) Vol. 41, Iss. 12, pp. 2019-2037.e8
Open Access | Times Cited: 38
A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment
Xianguang Yang, Baohong Zhang
Functional & Integrative Genomics (2023) Vol. 23, Iss. 2
Closed Access | Times Cited: 37
Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems
Rita Silva-Pedrosa, António J. Salgado, Pedro Eduardo Ferreira
Cells (2023) Vol. 12, Iss. 6, pp. 930-930
Open Access | Times Cited: 35
Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression
Sujata Jana, Sandipan Brahma, Sonali Arora, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 853-870.e13
Open Access | Times Cited: 30
Flourishing tumor organoids: History, emerging technology, and application
Qian Yang, Mengmeng Li, Xinming Yang, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 5
Open Access | Times Cited: 28
The role of organoids in cancer research
Zhen Fang, Peijuan Li, Fengying Du, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 25
Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair
Akira Ooki, Hiroki Osumi, Koichiro Yoshino, et al.
Gastric Cancer (2024) Vol. 27, Iss. 5, pp. 907-931
Open Access | Times Cited: 12
Tissue-location-specific transcription programs drive tumor dependencies in colon cancer
Lijing Yang, Lei Tu, Shilpa Bisht, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Let’s make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment
Mobina Bayat, Javid Sadri Nahand
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 9
Immune organoids: from tumor modeling to precision oncology
Vinh Dao, Kanako Yuki, Yuan‐Hung Lo, et al.
Trends in cancer (2022) Vol. 8, Iss. 10, pp. 870-880
Open Access | Times Cited: 38
Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1
Zhiping Feng, Marisa E. Hom, Thomas E. Bearrood, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 10, pp. 1065-1075
Open Access | Times Cited: 36
The dawn of precision medicine in diffuse-type gastric cancer
Akira Ooki, Kensei Yamaguchi
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 29
KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
Hong Qiu, Vladimir Makarov, Jennifer K. Bolzenius, et al.
Cancer Research (2023) Vol. 83, Iss. 6, pp. 814-829
Open Access | Times Cited: 22
Comprehensive molecular phenotyping ofARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities
Chang Xu, Kie Kyon Huang, Jia Hao Law, et al.
Gut (2023) Vol. 72, Iss. 9, pp. 1651-1663
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top